entity

GLP-1R agonists

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about GLP-1R agonists: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

18Connections

0Hypotheses

3Analyses

17Outgoing

1Incoming

0Experiments

4Debates

No AI portrait yet

Outgoing (17)

Target	Relation	Type	Str
Glucagon-Like Peptide-1 Receptor	targets	receptor	0.95
Type 2 Diabetes Mellitus	treats	disease	0.95
PI3K/Akt signaling pathway	activates	pathway	0.90
Parkinson's Disease	treats	disease	0.85
Dopamine	upregulates	compound	0.80
Dopaminergic Neuronal Loss	inhibits	process	0.80
Neuronal Degeneration	associated_with	process	0.80
Neuroinflammation	inhibits	process	0.80
Neuroprotection	mediates	process	0.80
Alzheimer's Disease	protects_against	disease	0.75
Parkinson's Disease	protects_against	disease	0.75
Motor Features	associated_with	phenotype	0.75
Non-Motor Features	associated_with	phenotype	0.75
GFAP	modulates	protein	0.70
M2 macrophage polarization	activates	process	0.50
M2 macrophage polarization	promotes	mechanism	0.50
astrogliosis	modulates	process	0.50

Incoming (1)

Source	Relation	Type	Str
29113464	could provide effective treatment for	paper	0.60

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (3)

Scientific analyses that reference this entity

Proteomics Differential Expression in AD CSF and Brain Tissue

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.865

How does engineered C. butyricum cross the blood-brain barrier to directly bind

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.699

What are the molecular mechanisms by which GLP-1RAs provide neuroprotective effe

neurodegeneration | 2026-04-14 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (4)

Multi-agent debates referencing this entity

Which proteins are differentially expressed in AD CSF and brain tissue, and do t

closed · Rounds: 4 · Score: 0.70 · 2026-04-21

Is a 12-protein CSF panel superior to existing plasma p-tau217 for clinical AD p

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

The study demonstrates significant reduction in dementia risk (HR 0.63) with GLP

closed · Rounds: 4 · Score: 0.95 · 2026-04-16

The abstract claims C. butyricum-GLP-1 crosses the BBB and binds to GLP-1 recept

closed · Rounds: 4 · Score: 0.95 · 2026-04-15

Related Research

Hypotheses and analyses mentioning GLP-1R agonists in their description or question text

No additional research found